Horizon Discovery Group plc (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announces that it has developed a set of precisely defined cell ...
Revvity, Inc., today announced the launch of new highly-characterized somatic cancer reference standards developed in collaboration with the Medical Device Innovation Consortium (MDIC) and the ...
A preliminary study by researchers from the Garvan Institute of Medical Research and the University of New South Wales and published on the preprint server bioRxiv* in June 2020 reports the use of ...
WALTHAM, Mass., November 10, 2025--(BUSINESS WIRE)--Revvity, Inc., today announced the launch of new highly-characterized somatic cancer reference standards developed in collaboration with the Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback